See also this year's filing and all EDGAR filings for this company.
PDF Report 0001672619_2022_Enliven_Therapeutics_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001672619')"} |
Graph
Absolute values for 0001672619, Enliven Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 92,696,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 250,000 |
3 | remainder_Assets | 700,000 |
4 | LiabilitiesCurrent | 7,210,000 |
5 | LiabilitiesNoncurrent | 406,000 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 13,000,000 |
9 | ResearchAndDevelopmentExpense | 38,442,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 58,000 |
13 | remainder_ComprehensiveNetIncome | -20,000 |
yvar | yval | |
---|---|---|
0 | Assets | 93,646,000 |
1 | Liabilities | 7,616,000 |
2 | Expenses | 51,442,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 86,030,000 |
5 | NetIncome | -51,384,000 |
6 | ComprehensiveNetIncome | -51,394,000 |
7 | BaseVar | 76,391,000 |
8 | EconomicCapitalRatio | 1.91 |